AstraZeneca
AZN
#50
Rank
โ‚ฌ245.01 B
Marketcap
157,99ย โ‚ฌ
Share price
1.29%
Change (1 day)
26.74%
Change (1 year)

Market capitalization of AstraZeneca (AZN)

Market cap: โ‚ฌ245.01 Billion

As of May 2026 AstraZeneca has a market cap of โ‚ฌ245.01 Billion. This makes AstraZeneca the world's 50th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AstraZeneca from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ245.01 B-0.02%
2025โ‚ฌ245.05 B25.25%
2024โ‚ฌ195.66 B3.4%
2023โ‚ฌ189.22 B-3.52%
2022โ‚ฌ196.13 B22.4%
2021โ‚ฌ160.23 B50.46%
2020โ‚ฌ106.49 B-8.84%
2019โ‚ฌ116.82 B41.54%
2018โ‚ฌ82.53 B13.67%
2017โ‚ฌ72.61 B10.75%
2016โ‚ฌ65.56 B-17.08%
2015โ‚ฌ79.07 B7.38%
2014โ‚ฌ73.64 B37.24%
2013โ‚ฌ53.65 B21.08%
2012โ‚ฌ44.31 B-4.92%
2011โ‚ฌ46.60 B-4.74%
2010โ‚ฌ48.92 B2.93%
2009โ‚ฌ47.53 B11.9%
2008โ‚ฌ42.48 B-0.58%
2007โ‚ฌ42.72 B-31.27%
2006โ‚ฌ62.17 B-5.64%
2005โ‚ฌ65.88 B49.4%
2004โ‚ฌ44.10 B-32.21%
2003โ‚ฌ65.05 B12.77%
2002โ‚ฌ57.69 B-37.35%
2001โ‚ฌ92.09 B-4.61%
2000โ‚ฌ96.54 B31.02%
1999โ‚ฌ73.68 B105.13%
1998โ‚ฌ35.92 B24.76%
1997โ‚ฌ28.79 B28.82%
1996โ‚ฌ22.35 B

End of Day market cap according to different sources

On May 18th, 2026 the market cap of AstraZeneca was reported to be:

โ‚ฌ489.98 Billion
by Nasdaq info icon info icon
โ‚ฌ245.01 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ473.36 B 93.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ244.46 B-0.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ124.01 B-49.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ131.53 B-46.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ756.88 B 208.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ89.60 B-63.43%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚ฌ24.33 B-90.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ238.80 B-2.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ100.52 B-58.97%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ86.67 B-64.63%๐Ÿ‡ฌ๐Ÿ‡ง UK